Keywords: actelion, files, japan, nda, tracleer, swiss, firm

Actelion files Japan NDA for Tracleer

Article | 14 April 2003

Swiss firm Actelion has submitted a New Drug Application for itspulmonary arterial hypertension drug Tracleer (bosentan) with the health authorities ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

bosentan

Tracleer

Go to drug listing